Immunobiology and treatment of cutaneous T-cell lymphoma.
CTCL
Cutaneous T cell lymphoma
Sezary syndrome
cutaneous oncology
immunotherapy
mycosis fungoides
Journal
Expert review of clinical immunology
ISSN: 1744-8409
Titre abrégé: Expert Rev Clin Immunol
Pays: England
ID NLM: 101271248
Informations de publication
Date de publication:
07 Mar 2024
07 Mar 2024
Historique:
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
7
3
2024
Statut:
aheadofprint
Résumé
Primary cutaneous T cell lymphomas (CTCL) are a heterogenous group of non-Hodgkin lymphomas derived from skin-homing T cells. These include mycosis fungoides and its leukemic variant Sezary syndrome, as well as the CD30+ lymphoproliferative disorders. In this review, we provide a summary of the current literature on CTCL, with a focus on the immunopathogenesis and treatment of mycosis fungoides and Sezary syndrome. Recent advances in immunology have provided new insights into the biology of malignant T cells. This in turn has led to the development of new therapies that modulate the immune system to facilitate tumor clearance or target specific aspects of tumor biology.
Identifiants
pubmed: 38450476
doi: 10.1080/1744666X.2024.2326035
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM